Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56.3M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
24.6M
-
Shares change
-
+1.22M
-
Total reported value, excl. options
-
$205M
-
Value change
-
+$5.96M
-
Put/Call ratio
-
0.74
-
Number of buys
-
45
-
Number of sells
-
-34
-
Price
-
$8.33
Significant Holders of Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS) as of Q2 2023
96 filings reported holding ATXS - Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share as of Q2 2023.
Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.6M shares
of 56.3M outstanding shares and own 43.74% of the company stock.
Largest 10 shareholders include FMR LLC (2.96M shares), PERCEPTIVE ADVISORS LLC (2.19M shares), Fairmount Funds Management LLC (1.9M shares), Deep Track Capital, LP (1.7M shares), Vivo Capital, LLC (1.68M shares), BlackRock Inc. (1.65M shares), VANGUARD GROUP INC (1.51M shares), Driehaus Capital Management LLC (1.46M shares), Altium Capital Management LP (1.35M shares), and Cormorant Asset Management, LP (1M shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.